Delivery Order SPE2DR25D3103-SPE2DR26F9J65
Award Date 11/25/25
Potential Completion Date 11/26/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $15,318.65 to AmerisourceBergen Drug Corp for the supply of Rexulti 3 mg tablets (30-count packaging) on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Rexulti is a prescription antipsychotic medication used in...
- The Defense Logistics Agency awarded a delivery order valued at $7,613.10 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (quantity: 30 count) under a firm fixed price contract. This non-competitive delivery order was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Rexulti (brexpiprazole) is an atypical antipsychotic medication used to treat schizophrenia and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically 30 tablets of Rexulti 0.5 mg, with a ceiling value of $21,979.66. This non-competitive delivery order carries a firm fixed price structure and an ultimate completion date of November 5, 2025. The order was awarded on November 4, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Rexulti is an antipsychotic...
- The Defense Logistics Agency awarded a delivery order valued at $21,377.39 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count packaging) under a firm fixed-price contract. This non-competitive, non-set-aside delivery order was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Rexulti is an atypical antipsychotic medication used in the...
- The Defense Logistics Agency awarded a delivery order valued at $16.79K to AmerisourceBergen Drug Corp for supply of Rexulti (brexpiprazole) 1 mg tablets in a 30-count package. This firm fixed price, non-set-aside delivery order was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Rexulti is a prescription antipsychotic medication used in treating major depressive disorder and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,450.54 on November 6, 2025, for Rexulti 2 mg tablets (30-count units). This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the company's existing contract vehicle with DLA. The order is scheduled for completion by November 7, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rexulti 1 mg tablets (30-count) valued at $5,894.80 under a firm fixed-price contract, with performance through August 21, 2025. This non-set-aside award was issued on August 20, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. Rexulti (brexpiprazole) is an atypical antipsychotic medication used in treating schizophrenia and major depressive disorder, reflecting DLA's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,281.82 on July 29, 2025, for the supply of Rexulti 2 mg tablets in quantities of 30. This firm fixed-price delivery order, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Rexulti is an atypical antipsychotic medication used in the...
- The Defense Logistics Agency awarded a delivery order valued at $3,495.08 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed price contract type. The order, issued on November 10, 2025, with an ultimate completion date of November 12, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,066.14 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count package) on November 14, 2025. This firm fixed-price delivery order, which is part of a larger competitively awarded contract vehicle, will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with completion targeted for November 17, 2025. The contract includes no set-aside designation, reflecting open competition...